Merit Financial Group, LLC Astrazeneca PLC Transaction History
Merit Financial Group, LLC
- $4.59 Billion
- Q3 2024
A detailed history of Merit Financial Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Merit Financial Group, LLC holds 4,723 shares of AZN stock, worth $307,183. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,723
Previous 7,432
36.45%
Holding current value
$307,183
Previous $579,000
36.44%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
475MCall Options Held
5.14MPut Options Held
3.06M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.09 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.73 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.42 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.39 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.25 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $202B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...